Life sciences · Preprint
arXiv · September 19, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The medications prescribed to a patient often change during a hospital admission as clinicians start, stop, or continue therapies. We study whether models can predict which medication classes are added or removed between 24 hours after admission and discharge. Metrics that compare the complete discharge regimen can reward models for copying medications that remain unchanged, even when they identify no actual changes. We therefore introduce a leakage-controlled benchmark that predicts net ATC3 additions and removals using only prior completed admissions and information available within the first 24 hours of the current admission. Addition candidates are classes not active at 24 hours, whereas removal candidates are classes active at that time. We also introduce R-GEAN, an asymmetric candidate-scoring network with independent addition and removal predictors. Across 240,480 admissions from 82,286 patients, R-GEAN achieves the highest predefined summary of addition, removal, changed-regimen, and action-pattern performance, termed the edit composite (0.464), compared with 0.435 for the strongest primary comparator. Reimplemented RETAIN, GAMENet, and MICRON baselines obtain 0.428, 0.420, and 0.288, respectively. R-GEAN's advantage is concentrated in correctly identifying medication classes no longer active at discharge, while rare additions and admissions with multiple medication changes remain difficult. Rankings based on micro-F1 over the reconstructed discharge regimen and the edit composite correlate weakly across the evaluated models (Spearman r = 0.20). The continuation baseline achieves the highest complete-regimen score despite predicting no additions or removals. These results show that complete-regimen and edit-level evaluation measure different aspects of medication prediction. The benchmark evaluates observed prescribing changes, not treatment appropriateness